Tab News

Professor Peter Dettmar and Professor Jeffery Pearson, world renowned experts in pepsin, will present key papers on gastroesophageal reflux disease in an international journal.

Professor Peter Dettmar has shared insight into how prevalent gastroesophageal reflux disease (GERD) is across the world in an article published in the international...

Peptest has proved valuable in helping identify symptoms of ‘silent reflux’ at NHS respiratory clinics at the Bristol Royal Infirmary.

Peptest and the importance of salivary pepsin detection was put under the spotlight at a forum in China, attended by our distributor Maxhealth.

Professor Peter Dettmar has provided insight into the diagnosis and treatment of reflux disease to a virtual conference of key opinion leaders in China.

Peptest could prove useful during the current Covid-19 pandemic when access to clinics and more complex clinical diagnostic procedures is restricted or delayed.

Restech, our distribution partner in the US, has launched a branded version of our reflux diagnostic saliva test – known as ‘PepsinCheck by Peptest’.

We’re delighted to announce that the Peptest laboratories will reopen for testing of saliva samples for pepsin on Monday 25 May. During the coronavirus...

In these difficult times with the Covid-19 (Coronavirus) outbreak, to protect our staff members, the majority of the RD Biomed and Peptest team will...

Peptest has proved valuable in helping identify symptoms of ‘silent reflux’ at NHS respiratory clinics at the Bristol Royal Infirmary.

Measuring salivary pepsin levels has the potential to reduce time to diagnose acid reflux, minimise the use of proton pump inhibitor (PPI) therapy, and...

Peptest is a useful, non-invasive diagnostic test for self-diagnosing reflux related symptoms, a study published in the EC Gastroenterology and Digestive System journal has...

Salivary pepsin detection is hailed a ‘simpler, more cost-effective and less traumatic universal first-line alternative’ to 24-hour pH monitoring in diagnosing laryngopharyngeal reflux disease...

Eye examinations could improve the management of patients with laryngopharyngeal reflux disease (LPR), according to a new study.

Laryngopharyngeal reflux (LPR), when gastric contents refluxes into the larynx/pharynx, can be diagnosed using a salivary pepsin test, researchers say.

Peptest has been identified as a ‘promising’ way to clinically diagnose patients with non-erosive reflux that doesn’t respond to medication in Japan study.

Children that take proton pump inhibitors medication (PPIs) are more likely to have asthma than those that don’t, a study published in JAMA Pediatrics...

Do you suffer from reflux-related symptoms? Northumbria University is looking for recruits to take part in a study investigating foods that trigger reflux and...

Regular exercise and healthier diets may reduce symptoms of reflux (GERD/GORD) substantially for some women and could even make medication unnecessary - a new...

Regular use of PPIs increases risk of developing type 2 diabetes by 24 per cent, an observational study published in Gut journal suggests.

Sleeping left-side down with your head and torso elevated is often suggested as a way of preventing night-time reflux.

Middle-aged women suffering from heartburn or regurgitation should avoid drinking coffee, tea or soda and stick to water, a new study suggests.

People with reflux disease often discover that there are certain things they do which make their symptoms worse. Making a few lifestyle modifications could...

Measuring salivary pepsin levels has the potential to reduce time to diagnose acid reflux, minimise the use of proton pump inhibitor (PPI) therapy, and...

Regular exercise and healthier diets may reduce symptoms of reflux (GERD/GORD) substantially for some women and could even make medication unnecessary - a new...

Medtech firm Implantica says its new RefluxStop device for treating acid reflux can ‘eliminate the need for proton-pump inhibitors (PPIs)’.

The Stretta system uses a special catheter or tube to deliver low-power and low-temperature radiofrequency energy to the muscle tissues in the LOS.

Proton pump inhibitors (PPIs) are one of the most commonly prescribed medications in the world - here's our at-a-glance guide to PPIs.

Iqoro - a device that helps to strengthens the oesophagus and diaphragm - has been recognised by the NHS healthcare watchdog for relieving symptoms...

A new study ‘Cashew gum, a biopolymer, topically protects oesophageal mucosa in nonerosive reflux disease: A promising translational study’ has looked at whether cashew...

Doctors in the UK have been told to stop prescribing four types of a heartburn medication called Zantac or ranitidine as a ‘precautionary measure’.

Alginate, a type of fibre found in seaweed, has been used to help with the symptoms of reflux disease for many years. Alginates naturally...